Publications & Guidelines

Since 2004, the Publications Committee has been charged with developing and publishing various publications, including the SMFM Consult Series and the SMFM Clinical Guidelines series published in the American Journal of Obstetrics & Gynecology. The Publications Committee collaborates with other Societies and Colleges to develop joint publications and statements, as appropriate. The Committee plans topics, selects authors, and reviews each completed paper before it is submitted for an internal SMFM review process and then for publication.  All Committee members have filed conflict of interest statements with SMFM. Any conflicts have been resolved through a process approved by the Executive Board. To facilitate transparency in SMFM's guideline development process, a brief overview of the key stages in development is provided here. Feedback for SMFM Publications is welcome at pubs@smfm.org

Coding : Coding Tips Coding : Coding White Papers Press Publications & Guidelines Publications & Guidelines : Administrative Publications & Guidelines : Consult Series Publications & Guidelines : Endorsed Partner Pub Publications & Guidelines : Health Policy Publication Publications & Guidelines : Joint Publication Publications & Guidelines : Obstetric Care Consensus Publications & Guidelines : Public/Global Health Publications & Guidelines : SMFM Special Report Publications & Guidelines : SMFM Statement

Putting the "M" back in MFM: Addressing education about disparities in maternal outcomes and care
Putting the "M" back in MFM: Addressing education about disparities in maternal outcomes and care

Download PDF CATEGORIES: Administrative Continue Reading

Date posted12/25/2018


SMFM Statement: Elective induction of labor in low-risk nulliparous women at term: The ARRIVE trial
SMFM Statement: Elective induction of labor in low-risk nulliparous women at term: The ARRIVE trial

The purpose of this document is to review the findings of a recent randomized trial of induction of labor versus expectant management in low-risk nulliparous women at 39 weeks of gestation, and to provide guidance for implementation of the study findings into practice. SMFM endorses the ACOG... Continue Reading

Date posted12/24/2018


Joint Committee Opinion #743, Low-dose aspirin use during pregnancy
Joint Committee Opinion #743, Low-dose aspirin use during pregnancy

Low-dose aspirin has been used during pregnancy, most commonly to prevent or delay the onset of preeclampsia. The American College of Obstetricians and Gynecologists issued the Hypertension in Pregnancy Task Force Report recommending daily low-dose aspirin beginning in the late first trimester for... Continue Reading

Date posted12/23/2018


SMFM Consult Series #45, Mild fetal ventriculomegaly: diagnosis, evaluation, and management
SMFM Consult Series #45, Mild fetal ventriculomegaly: diagnosis, evaluation, and management

Ventriculomegaly is defined as dilation of the fetal cerebral ventricles and is a relatively common finding on prenatal ultrasound. The purpose of this document is to review the diagnosis, evaluation, and management of mild fetal ventriculomegaly. When enlargement of the lateral ventricles (10... Continue Reading

Date posted12/22/2018


ACOG Committee Opinion #742 Postpartum pain management
ACOG Committee Opinion #742 Postpartum pain management

TAGS: pain management, Opioids, postpartum, Postpartum anxiety CATEGORIES: SMFM Endorsed Partner Publication Continue Reading

Date posted12/21/2018


ACOG Committee Opinion #736, optimizing postpartum care
ACOG Committee Opinion #736, optimizing postpartum care

ABSTRACT: The weeks following birth are a critical period for a woman and her infant, setting the stage for long-term health and well-being. To optimize the health of women and infants, postpartum care should become an ongoing process, rather than a single encounter, with services and support... Continue Reading

Date posted12/20/2018


SMFM Statement Pharmacological treatment of gestational diabetes
SMFM Statement Pharmacological treatment of gestational diabetes

The purpose of this SMFM Statement is to review the available scientific literature regarding pharmacological treatment of GDM and to provide additional guidance to obstetric care providers regarding treatment of these women. While this statement differs in some respects from the ACOG Practice... Continue Reading

Date posted12/19/2018


Joint Position Statement from ISPD, SMFM, and PQF on genome-wide sequencing for fetal diagnosis
Joint Position Statement from ISPD, SMFM, and PQF on genome-wide sequencing for fetal diagnosis

Download PDF TAGS: fetal anomalies, fetal complications, screening, genetic screening, genetic CATEGORIES: Joint Publication Continue Reading

Date posted12/18/2018


ACOG SMFM OCC#6, Periviable birth
ACOG SMFM OCC#6, Periviable birth

Approximately 0.5% of all births occur before the third trimester of pregnancy, and these very early deliveries result in the majority of neonatal deaths and more than 40% of infant deaths. A recent executive summary of proceedings from a joint workshop defined periviable birth as delivery... Continue Reading

Date posted12/31/2017


Research to knowledge: promoting the training of physician-scientists in the biology of pregnancy
Research to knowledge: promoting the training of physician-scientists in the biology of pregnancy

Common disorders of pregnancy, such as preeclampsia, preterm birth, and fetal growth abnormalities,continue to challenge perinatal biologists seeking insights into disease pathogenesis that will result in better diagnosis, therapy, and disease prevention. These challenges have recently been... Continue Reading

Date posted12/30/2017


SMFM Consult Series #44, Management of bleeding in the late preterm period
SMFM Consult Series #44, Management of bleeding in the late preterm period

Third-trimester bleeding is a common complication arising from a variety of etiologies, some of which may initially present in the late preterm period. Previous management recommendations have not been specific to this gestational age window, which carries a potentially lower threshold for... Continue Reading

Date posted12/29/2017


Joint Committee Opinion #720, Maternal-fetal surgery for myelomeningocele
Joint Committee Opinion #720, Maternal-fetal surgery for myelomeningocele

Myelomeningocele, a severe form of spina bifida, occurs in approximately 1 in 3,000 live births in the United States. The extent of disability is generally related to the level of the myelomeningocele defect, with a higher upper level of lesion generally corresponding to greater deficits. Open... Continue Reading

Date posted12/28/2017